Scinai Immunotherapeutics Ltd. (SCNI) stock
SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.37−0.01 (-1.40%)
Close on Nov 18, 2026Market cap $1.27MP/E –Yield –
Scinai Immunotherapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Scinai Immunotherapeutics's pe ratio was 6.4× on Feb 27, 2026, against 2.2× a year earlier. Over the last 3 years it ranged from 1.2× to 6.4×, with a median of 2.9×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Feb 27, 2026 | 6.4× | +4.2 |
| 2025 | Dec 31, 2025 | 2.2× | +0.2 |
| 2024 | Dec 31, 2024 | 2.1× | +0.6 |
| 2023 | Dec 29, 2023 | 1.5× | – |
See a number that looks wrong?